CBD oil put to the test for kids with Hard-to-Control seizures
NCT ID NCT07668856
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether cannabidiol (CBD) oil can reduce seizures in children aged 1 to 18 with severe epilepsy that doesn't respond to standard treatments. Each child will receive both CBD and a placebo in alternating periods, and their seizures will be tracked using a smartphone app. The goal is to see if CBD works better than placebo for each individual child, while also monitoring safety and side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Cannabidiol (CBD) oral solution
What this could lead to
If it works, this could provide a personalized treatment option for children with hard-to-control epilepsy, reducing seizure frequency and improving quality of life.
What could go wrong
This is a small Phase 3 trial with only 50 participants, and results may not apply to all children. CBD may cause side effects like drowsiness or liver issues, and the benefit over placebo may be modest or absent for some.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Medical Center Utrecht
RECRUITINGUtrecht, Utrecht, 3584 CX, Netherlands